Skip to main content
  1. Right Decisions
  2. GGC - Clinical Guidelines
  3. Paediatrics
  4. Back
  5. Emergency Medicine (Paediatric)
  6. Adrenal insufficiency in children, emergency and acute management guidance, paediatrics (239)
Update your RDS mobile app to v4.7.2 to download toolkits even when website is down.

We are pleased to advise that deep linking capability, enabling users to directly download individual mobile toolkits, has now been released on the RDS mobile app. You will see that each toolkit has a small QR code icon in the header area beside the search icon – see screenshot below. Clicking on this icon will open up a window with a full-size QR code and the alternative of a short URL for sharing with users. Instructions are provided.

You may need to actively update to the latest release - RDS app version 4.7.1 - to see this improvement.

Updating to this latest version of the RDS app is also strongly recommended to get the full benefits of the new resilience  arrangements – specifically, that if the RDS website should fail, you will still be able to download new mobile app toolkits. To check your current RDS version, click on the three dots bottom right of the RDS app screen. This takes you to a “More” page where you will see the version number.  To install latest updates:

On iPhones – go to the Apple store, click on your profile icon top right, scroll down to see the apps waiting to be updated and update the RDS app.

On Android phones – these can vary, but try going to the Google Play store, click on your profile icon top right, click on “Manage apps and device”, select and update the RDS app.

Please get in touch with ann.wales3@nhs.scot with any questions.

Adrenal insufficiency in children, emergency and acute management guidance, paediatrics (239)

Warning

Objectives

Standardisation of the emergency management of acutely unwell children with known or suspected adrenal insufficiency.

Scope

This clinical guidance should be used in children with known or suspected adrenal insufficiency who present acutely unwell.

Conditions: 

Children on daily replacement hydrocortisone treatment, eg.

  • Congenital Adrenal Hyperplasia
  • Congenital Adrenal Hypoplasia
  • Addison’s disease
  • Hypopituitarism eg congenital, brain tumour and post-radiotherapy

Children on high dose glucocorticoid treatment (Prednisolone, Deflazacort, Dexamethasone, Vamorolone) eg Inflammatory conditions like inflammatory arthritis, inflammatory bowel disease, Duchenne muscular dystrophy.

Source for guidance

This clinical guidance adopts recommendations from the UK National Paediatric Adrenal Insufficiency Emergency Management Guidance developed by the British Society for Paediatric Endocrinology and Diabetes (2022). The British Society for Paediatric Endocrinology and Diabetes guidance has also been incorporated into the NICE guideline [NG243] Adrenal insufficiency: Identification and management (Published 28th August 2024).

EMERGENCY MANAGEMENT OF SUSPECTED ADRENAL CRISIS (SEVERE ILLNESS OR STRESS): REQUIRE IM OR IV HYDROCORTISONE

Need for IM or IV hydrocortisone.

DO NOT DELAY ADMINISTRATION OF IM or IV HYDROCORTISONE WITH SUSPECTED ADRENAL CRISIS.  PATIENTS WITH SUSPECTED ADRENAL CRISIS COULD DETERIORATE RAPIDLY EVEN IF APPEAR WELL.

INITIAL MANAGEMENT OF SUSPECTED ADRENAL CRISIS

  • Administer IV bolus or IM hydrocortisone
  • Manage acute presentation as appropriate (treat the underlying cause)

IM or initial IV bolus hydrocortisone doses for suspected adrenal crisis

Age

Dose of hydrocortisone (IM or initial IV bolus)

Less than 1 year

25 mg

1 to 5 years

50 mg

6 years and over

100 mg

Indications:

  • Acutely unwell with diarrhoea and vomiting
  • Reduced responsiveness or loss of consciousness
  • Hypoglycaemia or new onset seizure in known or suspected adrenal insufficiency
  • Painful fracture or fractures with significant deformity
  • Significant burn
  • Major trauma or severe shock (eg road traffic accident, head injury with loss of consciousness

On arrival to hospital, check blood glucose as soon as possible.
If blood glucose < 3 mmol/L, give 3 ml/kg of 10% dextrose as bolus.
Recheck blood glucose in 15 min and repeat bolus if necessary.

If shock or moderate to severe dehydration, give 10 ml/kg of 0.9% sodium chloride and repeat if necessary.
Check electrolytes at presentation to inform fluid usage.

SUBSEQUENT MANAGEMENT OF SUSPECTED ADRENAL CRISIS

Following bolus of IV/IM hydrocortisone the child should be started on a hydrocortisone infusion

Hydrocortisone infusion for acute illness

Weight

Total dose in 24 hours

Infusion rate
(50mg hydrocortisone in 50ml 0.9% sodium chloride)

≤10kg

25 mg

1 ml/hr

10.1 to 20kg

50 mg

2 ml/hr

20.1 to 40kg

100 mg

4 ml/hr

40.1 to 70kg

150 mg

6 ml/hr

Over 70kg

200 mg

8 ml/hr

To make up hydrocortisone infusion

  • Add 50 mg hydrocortisone in 50 ml 0.9% sodium chloride
  • Hydrocortisone infusion can run alongside 0.9% sodium chloride or 5% glucose or PlasmaLyte solutions
  • Consider more concentrated infusions in those needing fluid restriction (eg 100 mg hydrocortisone in 50 ml 0.9% sodium chloride)

Maintenance fluid type

0.9% sodium chloride / 5 % glucose is usually an appropriate starting point.

Hyperkalaemia: Children with primary adrenal insufficiency can be hyperkalaemic at presentation or in an adrenal crisis because of mineralocorticoid deficiency. Emergency management of adrenal crisis with IV glucocorticoids and IV fluids (0.9% sodium chloride) will reduce potassium levels. Hyperkalaemia is potentially life-threatening and can lead to cardiac arrhythmias. Additional measures such as the use of IV calcium gluconate, nebulised salbutamol, IV insulin and glucose or IV bicarbonate and cation exchange resins should also be considered. 23

Hyponatraemia and fluids: Sodium chloride 0.9%/5% glucose is usually a good starting point for initial fluid management if the clinical and biochemical picture suggest that the low sodium has arisen primarily because of salt wasting.

  • In primary adrenal insufficiency (eg Addison’s disease, Congenital adrenal hyperplasia), mineralocorticoid deficiency will cause hyponatraemia due to renal losses.
  • In secondary adrenal insufficiency (eg hypopituitarism, patients with brain tumours or post-radiotherapy, patients on long term treatment dose of glucocorticoid eg Prednisolone, Deflazacort, Dexamethasone), cortisol deficiency can lead to a lack of free water clearance which can contribute to hyponatraemia. In this latter scenario (those with secondary adrenal insufficiency), a degree of fluid restriction may be more appropriate.

Fludrocortisone is an oral mineralocorticoid used in primary adrenal insufficiency. The dose does not need adjustment in the event of a sick day episode or an adrenal crisis. If the child is unable to take oral medication then IV fluids may be required to maintain the salt and water balance depending on the clinical situation. However, the mineralocorticoid effect of hydrocortisone at stress doses is often sufficient to cover the mineralocorticoid requirement. Oral fludrocortisone should be re-commenced when able to tolerate oral medication.

EMERGENCY MANAGEMENT OF SICK DAY EPISODE (MODERATE ILLNESS OR STRESS): REQUIRE ORAL SICK DAY DOSING

Need for oral sick day dosing

Indications:

  • Acute infections/childhood illnesses with fever (usually not well enough to go to school)
  • Vomiting or diarrhoea (only if tolerating oral medication and fluid but low threshold for consideration for IM or IV therapy)

Oral sick day dosing based on weight.

A guide to sick day dosing that can safely be used in the emergency setting is provided below. However, the actual dose may vary depending on the strength and preparation of the available hydrocortisone medication. Rounding up to the next 0.5 mg dosing is appropriate. Sick day dosing should be given for the duration of the illness. Patients own personalized sick day dosing plans from clinical review within the last 6 months (if available) can also be used.

Patients should should be advised to ring primary medical team if no improvement after 48 hours or if further deterioration on oral sick day dosing following discharge from the hospital/A&E.

For patients on treatment dose of glucocorticoid (eg Prednisolone, Deflazacort), a simple and safe approach is for additional sick day hydrocortisone to ensure adequate plasma cortisol levels throughout the day and night, on top of usual treatment dose of glucocorticoid (eg Prednisolone, Deflazacort). This is relevant as the half-life of Deflazacort is 1.5 to 1.9 hours; and the half-life of Prednisolone is 2.0 to 4.0 hours. The treatment dose of glucocorticoid (eg Prednisolone, Deflazacort) does not need to be altered during sick day episodes.

Weight(kg)

Sick day hydrocortisone:
Dose

Frequency

1

0.8 mg

4 x a day

2

1.2 mg

4 x a day

3

1.5 mg

4 x a day

4

2.0 mg

4 x a day

5

2.5 mg

4 x a day

6

2.5 mg

4 x a day

7

3.0 mg

4 x a day

8

3.0 mg

4 x a day

9

3.5 mg

4 x a day

10

4.0 mg

4 x a day

15

5.0 mg

4 x a day

20

6.0 mg

4 x a day

25

7.5 mg

4 x a day

30

7.5 mg

4 x a day

35

10.0 mg

4 x a day

40

10.0 mg

4 x a day

45

10.0 mg

4 x a day

50

10.0 mg

4 x a day

55

12.5 mg

4 x a day

60

12.5 mg

4 x a day

65

12.5 mg

4 x a day

70

15.0 mg

4 x a day

75

15.0 mg

4 x a day

80

15.0 mg

4 x a day

90

15.0 mg

4 x a day

EMERGENCY MANAGEMENT OF SICK DAY EPISODE (MILD ILLNESS OR STRESS): NO NEED FOR SICK DAY DOSING

No need for sick day dosing (ie no change to usual treatment)

Indications:

  • Mild cold or runny nose with no fever.
  • Minor playground bumps and bruises